Combination Drug Delivery Approach as an Effective Therapy for Various Diseases

Häftad, Engelska, 2022

2 529 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Combination Drug Delivery Approach as an Effective Therapy for Various Diseases explores the use of bioengineering tools in combination drug delivery approaches to control various diseases at different clinical stages of synergistic action, varying mechanisms of action, and during the suppression of drug resistance. The book presents fundamental knowledge on the experiential and experimental aspects of drug combination approaches in order to equip rational applications in preventing the emergence of resistance during the treatment of various diseases. It provides a holistic understanding of the principles behind formation, characterization, applications, regulations, toxicity, challenges and future perspectives of combination drug delivery approaches.

It will be of interest to researchers and advanced graduate students in pharmaceutical science, chemistry, biology and medicine, as well as pharmaceutical companies and scientific organizations.

Provides an accounting of vital aspects on various combination drug delivery approaches, presenting next generation diagnostics and therapeutics
Discusses the perspectives of current technologies in highly organized tables, illustrative figures and flow charts
Defines major gaps in knowledge that can lead to significant scientific discoveries

Produktinformation

Utgivningsdatum:2022-04-18
Mått:191 x 235 x 23 mm
Vikt:910 g
Format:Häftad
Språk:Engelska
Antal sidor:436
Förlag:Elsevier Science
ISBN:9780323858731

Utforska kategorier

Farmakologi inom Medicin
Biokemisk teknik inom Naturvetenskap och teknik
Organisk kemi inom Naturvetenskap och teknik

Mer om författaren

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

Innehållsförteckning

Section 1: Combination drug delivery approaches against various diseases1. Drug resistance as challenges to effective therapy2. Overcoming the challenges of drug resistance through combination drug delivery approach3. Combination drug delivery approaches for pulmonary diseases4. Combination drug delivery approaches in ophthalmology5. Combination drug delivery system to enhance the transdermal drug delivery6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis7. Combination drug delivery approaches for cardiovascular disease8. Combination drug delivery approaches for viral infection9. Combination drug delivery approaches for malaria parasite10. Combination drug delivery approaches for tuberculosisSection 2: Combination drug delivery approaches against cancer11. Combination drug delivery approaches for cancer therapy12. Prodrug-based drug delivery approaches in cancer combination therapy13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics14. Cocktail chemotherapy by combination drug delivery systems15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy16. Combinational chemotherapy and hyperthermia in cancer treatmentSection 3: Combination drug delivery approaches challenges and future perspectives17. Premarket review and postmarket regulation of combination drug products18. Challenges associated with nanoparticulate combination drug delivery systems19. Concluding remarks and future perspective of combination drug delivery systems